ARTICLE | Distillery Therapeutics
Therapeutics: ST3 β-galactoside α-2,3-sialyltransferase 4 (ST3GAL4)
September 24, 2015 7:00 AM UTC
Mouse studies suggest inhibiting ST3GAL4 or sialidases to limit intestinal growth of Escherichia coli could help treat colitis. In normal mice, ST3GAL4 knockout decreased intestinal numbers of E. coli...